References
Niadeut P (2018) Etiology, clinical manifestations, and diagnosis of nephrotic syndrome in children. UpToDate. https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-nephrotic-syndrome-in-children. Accessed 21 Nov 2018
Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757
Niaudet P, Boyer O (2016) Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED et al (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 840–869
Van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008)Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310
Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181
Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600
Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32:249–251
Klasen IS, Göertz JH, van de Wiel GA, Weemaes CM, van der Meer JW, Drenth JP (2001)Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 8:58–61
Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P, SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie), CRI (Club Rhumatismes et Inflammations) (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:152–159
Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483
Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double- blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226
Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27:1317–13120
Simms RW, Prout MN, Cohen AS (1994) The epidemiology of AL and AA amyloidosis. Bailliere’s Clin Rheumatol 8:627–634
Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203
Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine 73:133–144
Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JW, Drenth JP (2004) Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 62:994–997
Joroen CH, van der Hilst JC, Frenkel J (2010) Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep 12:101–107
Padeh YC, Rubinstein A (2018) Hyperimmunoglobuline D syndrome: pathophysiology. UpToDate. https://www.uptodate.com/contents/hyperimmunoglobulin-d-syndrome-pathophysiology. Accessed 16 Jan 2018
Kostjukovits S, Kalliokoski L, Antila K, Korppi M (2015) Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr 174:707–714
Musters A, Tak PP, Baeten DL, Tas SW (2015)Anti-interleukin 6 receptor therapy for hyper-IgD syndrome. BMJ Case Rep. https://doi.org/10.1136/bcr-2015-210513
Mulders-Manders CM, Simon A (2015)Hyper-IgDsyndrome/mevalonate kinase deficiency: what is new? Semin Immunopathol 37:371–376
Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48:41–45
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent statement
Informed consent was obtained from the parents of the patient.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-019-04381-w.
Rights and permissions
About this article
Cite this article
Guliyeva, L., Tabel, Y., Düzova, A. et al. A rare cause of steroid-resistant nephrotic syndrome in a child: Answers. Pediatr Nephrol 35, 621–623 (2020). https://doi.org/10.1007/s00467-019-04385-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04385-6